Volume 10, Issue 4
Editorialp. 207
How we can improve the predictive value of prognostic biomarkers in rheumatoid arthritis
Author(s): L Soto, D Catalan, JC Aguillon & M Cuchacovich
Editorialp. 211
Academic Health Science Networks: a new approach for driving health innovation
Author(s): J Goodacre & L Butland
Commentaryp. 215
Is there evidence indicating a link between periodontitis and rheumatoid arthritis?
Author(s): PM Bartold & SM Proudman
Commentaryp. 219
Obstructive sleep apnea, hypoxia and inflammatory arthritis: how may they be linked?
Author(s): RM Taylor-Gjevre
Commentaryp. 223
What impact do race and ethnicity have on lupus mortality?
Author(s): JA Gomez-Puerta & G Vasquez
Perspective Articlep. 227
What is the best treatment option for granulomatosis with polyangiitis?
Author(s): C Comarmond & P Cacoub
Perspective Articlep. 235
How can the treatment of rheumatoid arthritis be improved in Japan?
Author(s): T Koike & K Inui
Perspective Articlep. 245
What is the best strategy in treating catastrophic antiphospholipid syndrome?
Author(s): I Rodriguez-Pinto, I Santacreu, R Cervera & G Espinosa
Review Articlep. 257
Utility of dermatomyositis-specific autoantibodies for diagnosis and clinical subsetting
Author(s): S Sato & M Kuwana
Review Articlep. 273
Temporomandibular joint arthritis in juvenile idiopathic arthritis: the last frontier
Author(s): ML Stoll & RQ Cron
Review Articlep. 287
Biomarkers for knee osteoarthritis: new technologies, new paradigms
Author(s): L Spain, B Rajoub, DK Schluter, J Waterton, M Bowes, L-K Shark, P Diggle & J Goodacre
